The panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who could benefit.

The Class I recall status indicates that the product poses a risk of causing serious health consequences or death if consumed ...

An agency-sponsored forum included critics of psychiatry who believe the drugs can harm a developing fetus. Other experts ...

Doctors on Monday urged the U.S. Food and Drug Administration to issue warnings to pregnant women against the use of certain ...

Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...

Sarepta Therapeutics is refusing to pull its gene therapy Elevidys (delandistrogene moxeparvovec), despite a request from the FDA.

A standoff over Elevidys could have major consequences for Duchenne patients, gene therapy companies and the perception of ...

The Food and Drug Administration is shifting its annual COVID-19 vaccine approval policies to focus on Americans older than age 65 and other "high-risk" individuals, while increasing the standard ...

The FDA subsequently issued is Class I risk classification on July 3. Vita Warehouse Corp. issued a voluntary recall for more than 40,000 bottles of Vitamin B12 supplements on June 12 because of ...

Ginger Beer Recall Update as FDA Issues Highest Risk Warning. Published Jun 19, 2025 at 10:04 AM EDT. By . Jasmine Laws is a US News Reporter at Newsweek based in London, U.K.

In a major policy change, the Food and Drug Administration has announced a plan to limit access to future COVID-19 shots only to people over 65 years old or those with an underlying health condition.

The FDA will prioritize approval of COVID-19 vaccines which can be proven to generate antibody titers in people over age 65 or people who are 6 months or older and at high risk for severe disease ...